Skip to content
  • Mediacenter
  • Literature Database
  • Investor News
  • Careers
  • Get in Contact
International (English)
Locale
CytoSorbents Europe GmbH
International (English)
Locale
Hotline
  • COVID-19
    • Global decision support
  • The Therapy
    • Therapeutic aspects
    • Ticagrelor and Rivaroxaban
    • Fields of application for the CytoSorb Therapy
    • CytoScore in septic shock
    • Background
    • Product safety
    • Testimonials
  • The Studies
    • Multicenter Studies
    • Monocenter studies
    • The CytoSorb-Registry
    • Case of the week Submission
  • The Adsorber
    • Setup of CytoSorb
    • Usage and Application
    • Technical data
    • Q&A
  • Events
    • Event review
  • Support
    • Mediacenter
    • Reimbursement & Coding of CytoSorb Therapy
    • Newsletter Registration
    • Hotline
  • About us
    • Corporation Management
    • CytoSorbents worldwide
    • Scientific partners
    • Careers
    • Get in Contact

Hemoadsorption with CytoSorb in various cardiac surgery indications

Role of CytoSorb hemoadsorption therapy in endocarditis patients

CytoSorbents Introduction EACTS 2020

Removal of Ticagrelor during emergency heart surgery – reduction of complications and costs

Mitral valve endocarditis – new chances to improve the outcome

Aortic surgery – modulation of the inflammatory response

Successful treatment of rhabdomyolysis following heart transplantation

Le patient chirurgical d’urgence sous Ticagrelor (Sous-titres français)

The emergency surgical patient under Ticagrelor (Polish Subtitles)

The emergency surgical patient under Ticagrelor

  • 1
  • 2
  • 3
  • Next
CytoSorbents Europe GmbH
Facebook-f Twitter Linkedin Youtube

CytoSorbents Europe GmbH
Müggelseedamm 131
12587 Berlin

support(at)cytosorbents.com

©2022 CYTOSORBENTS EUROPE GMBH | ALL RIGHTS RESERVED

*Cytosorb Therapy is the use of the CytoSorb adsorber in conditions where elevated levels of Cytokines and/or Bilirubin and/or Myoglobin exist. CytoSorb can also be used intraoperatively for the removal of Ticagrelor and/or Rivaroxaban during Cardiopulmonary-Bypass.

  • Privacy Information
  • Data protection
  • Disclaimer
  • Imprint
CytoSorbents Europe GmbH
  • COVID-19
    • Global decision support
  • The Therapy
    • Therapeutic aspects
    • Ticagrelor and Rivaroxaban
    • Fields of application for the CytoSorb Therapy
    • CytoScore in septic shock
    • Background
    • Product safety
    • Testimonials
  • The Studies
    • Multicenter Studies
    • Monocenter studies
    • The CytoSorb-Registry
    • Case of the week Submission
  • The Adsorber
    • Setup of CytoSorb
    • Usage and Application
    • Technical data
    • Q&A
  • Events
    • Event review
  • Support
    • Mediacenter
    • Reimbursement & Coding of CytoSorb Therapy
    • Newsletter Registration
    • Hotline
  • About us
    • Corporation Management
    • CytoSorbents worldwide
    • Scientific partners
    • Careers
    • Get in Contact
APPLY TODAY
JOBS
International (English)
  • Privacy Policy
  • Data protection
  • Disclaimer
  • Imprint